Insider · CIK 0001813775

Baroldi Joseph

Reports to the SEC for 2 companies · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001813775

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+3,866 sh	$56.78	+$220K	8,535
2026-06-26	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+1,769 sh	$32.60	+$57.7K	10,304
2026-06-26	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−5,635 sh	$80.16	−$452K	4,669
2026-06-26	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−1,769 sh	—	—	0
2026-06-26	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−3,866 sh	—	—	0
2026-04-28	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−1,626 sh	$71.79	−$117K	44,909
2026-04-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−5,619 sh	$74.56	−$419K	46,535
2026-04-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+10.8K sh	—	—	52,154
2026-04-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−10.8K sh	—	—	48,312
2026-03-04	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−201 sh	—	—	1,769
2026-03-04	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−238 sh	—	—	3,866
2026-03-04	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−238 sh	$80.00	−$19K	4,347
2026-03-04	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+201 sh	$32.60	+$6,552.6	4,548
2026-03-04	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+238 sh	$56.78	+$13.5K	4,585
2026-03-04	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−201 sh	$80.00	−$16.1K	4,347
2026-03-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−2,088 sh	$80.41	−$168K	4,383
2026-03-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−36 sh	$81.01	−$2,916.36	4,347
2026-03-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+879 sh	$32.60	+$28.7K	6,471
2026-03-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+820 sh	$56.78	+$46.6K	5,592
2026-03-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−4,096 sh	$79.36	−$325K	41,317
2026-03-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−820 sh	—	—	4,104
2026-03-03	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−879 sh	—	—	1,970
2026-01-30	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−5,296 sh	$82.96	−$439K	45,413
2026-01-29	IONSIONIS PHARMACEUTICALS INCA Award	EVP, Chief Business Officer	AAward	+10.3K sh	—	—	50,709
2026-01-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−6,907 sh	$75.75	−$523K	40,431
2026-01-16	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−1,149 sh	$75.78	−$87.1K	4,772
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−2,850 sh	—	—	5,474
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−17K sh	—	—	49,474
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Performance Restricted Stock UnitsA Award	EVP, Chief Business Officer	AAward	+25.8K sh	—	—	77,090
2026-01-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+2,850 sh	—	—	5,921
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chief Business Officer	AAward	+9,675 sh	—	—	59,149
2026-01-15	IONSIONIS PHARMACEUTICALS INC · Restricted Stock UnitA Award	EVP, Chief Business Officer	AAward	+3,900 sh	—	—	9,374
2026-01-15	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+17K sh	—	—	47,338
2026-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chief Business Officer	AAward	+2,600 sh	—	—	2,600
2026-01-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	EVP, Chief Business Officer	AAward	+19.4K sh	—	—	19,350
2025-10-06	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−1,625 sh	$69.37	−$113K	30,301
2025-10-02	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+15K sh	$31.80	+$477K	46,926
2025-10-02	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−15K sh	$68.01	−$1.02M	31,926
2025-10-02	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−15K sh	—	—	26,700
2025-09-09	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+12K sh	$31.80	+$380K	43,876
2025-09-09	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−12K sh	—	—	41,700
2025-09-09	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−12K sh	$62.16	−$743K	31,926
2025-09-05	IONSIONIS PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−250 sh	—	—	53,650
2025-09-05	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−250 sh	$62.00	−$15.5K	31,926
2025-09-05	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+250 sh	$31.80	+$7,950	32,176
2025-09-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−2,800 sh	$62.01	−$174K	31,926
2025-09-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+2,800 sh	$31.80	+$89K	34,726
2025-09-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+15K sh	$31.80	+$477K	46,926
2025-09-03	IONSIONIS PHARMACEUTICALS INCS Sale	EVP, Chief Business Officer	SSale	−30K sh	$59.09	−$1.77M	16,926
2025-09-03	IONSIONIS PHARMACEUTICALS INCM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+15K sh	$31.80	+$477K	31,926

Recent filings

Accepted (ET)
Jun 304
Baroldi Joseph0000874015-26-000218
SEC(opens sec.gov)
Apr 304
Baroldi Joseph0000874015-26-000179
SEC(opens sec.gov)
Apr 174
Baroldi Joseph0000874015-26-000169
SEC(opens sec.gov)
Mar 54
Baroldi Joseph0000874015-26-000133
SEC(opens sec.gov)

Companies

Address

2855 GAZELLE COURT

CARLSBAD, CA, 92010